Start an analysis for MYSE
Myseum.AI, Inc.
Stock · NASDAQProgram summary
| Field | Value | As of | Source |
|---|---|---|---|
| Current authorization | $2m | 30-Sep-26 | 10-Q filed 16-Nov-26 |
| Remaining authorization | $2mEST | 30-Sep-26 | 10-Q filed 16-Nov-26 |
| Program expiry | n/a | — | |
| Repurchased last quarter | Not found in filings | — | |
| Has used an ASR | No | — |
Remaining authorization is estimated: we derive it from reported spend, or convert a share authorization at the latest close. Check the linked filings.
Programs
| Authorized on | Authorized | Remaining | Expires | Terms |
|---|---|---|---|---|
| 06-Jan-23 | $2m | $2mEST | n/a | On January 6, 2023, the Board of Directors of the Company approved a stock repurchase program authorizing the purchase of up to $ 2 million of the Company’s common stock (the “2023 Stock Repurchase Program”).10-Q filed 16-Nov-26 |
Open-market repurchases
None reported in the filings we hold.